Cargando…

Risk factors and trajectories of opioid use following total knee replacement

BACKGROUND: Opioids are commonly used to manage orthopedic pain in those undergoing total knee arthroplasty (TKA). There are limited studies assessing patterns of perioperative opioid use and risk factors for chronic use in patients undergoing TKA. METHODS: This is a retrospective longitudinal cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Ralph, Taber, David, Gonzales, Haley, Gebregziabher, Mulugeta, Basco, William, McCauley, Jenna, Mauldin, Patrick, Ball, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981598/
https://www.ncbi.nlm.nih.gov/pubmed/35382897
http://dx.doi.org/10.1186/s43019-022-00148-0
_version_ 1784681635523854336
author Ward, Ralph
Taber, David
Gonzales, Haley
Gebregziabher, Mulugeta
Basco, William
McCauley, Jenna
Mauldin, Patrick
Ball, Sarah
author_facet Ward, Ralph
Taber, David
Gonzales, Haley
Gebregziabher, Mulugeta
Basco, William
McCauley, Jenna
Mauldin, Patrick
Ball, Sarah
author_sort Ward, Ralph
collection PubMed
description BACKGROUND: Opioids are commonly used to manage orthopedic pain in those undergoing total knee arthroplasty (TKA). There are limited studies assessing patterns of perioperative opioid use and risk factors for chronic use in patients undergoing TKA. METHODS: This is a retrospective longitudinal cohort study of Medicaid enrollees undergoing TKA between 2014 and 2017 using de-identified medical and pharmacy claims. The primary outcome was chronic opioid use (opioid prescription filled 90–270 days following TKA). Trajectory group membership was determined by identifying distinct groups of patients with similar patterns of daily morphine milligram equivalent (MME) values during the postsurgery follow-up period. RESULTS: In total, 1666 TKA surgeries performed in 1507 patients were included; 69% of patients were classified as chronic opioid users. Multivariable analyses identified prior opioid use, high opioid doses during the month after TKA, concomitant mood therapies and benzodiazepines, and comorbid conditions as important risk factors. Group-based trajectory analysis identified five distinct post-TKA surgery opioid use phenotypes with several key characteristics predicting group membership. CONCLUSIONS: This large-scale analysis demonstrated that chronic opioid use was common after TKA surgery and established several important risk factors for chronic use following TKA. Novel analysis revealed five distinct opioid use trajectories and identified key characteristics to help guide clinicians when determining perioperative opioid use. Results demonstrate that interventional studies attempting to reduce opioids after TKA are needed if reductions in long-term use are to be realized in this high-risk patient population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43019-022-00148-0.
format Online
Article
Text
id pubmed-8981598
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89815982022-04-06 Risk factors and trajectories of opioid use following total knee replacement Ward, Ralph Taber, David Gonzales, Haley Gebregziabher, Mulugeta Basco, William McCauley, Jenna Mauldin, Patrick Ball, Sarah Knee Surg Relat Res Research Article BACKGROUND: Opioids are commonly used to manage orthopedic pain in those undergoing total knee arthroplasty (TKA). There are limited studies assessing patterns of perioperative opioid use and risk factors for chronic use in patients undergoing TKA. METHODS: This is a retrospective longitudinal cohort study of Medicaid enrollees undergoing TKA between 2014 and 2017 using de-identified medical and pharmacy claims. The primary outcome was chronic opioid use (opioid prescription filled 90–270 days following TKA). Trajectory group membership was determined by identifying distinct groups of patients with similar patterns of daily morphine milligram equivalent (MME) values during the postsurgery follow-up period. RESULTS: In total, 1666 TKA surgeries performed in 1507 patients were included; 69% of patients were classified as chronic opioid users. Multivariable analyses identified prior opioid use, high opioid doses during the month after TKA, concomitant mood therapies and benzodiazepines, and comorbid conditions as important risk factors. Group-based trajectory analysis identified five distinct post-TKA surgery opioid use phenotypes with several key characteristics predicting group membership. CONCLUSIONS: This large-scale analysis demonstrated that chronic opioid use was common after TKA surgery and established several important risk factors for chronic use following TKA. Novel analysis revealed five distinct opioid use trajectories and identified key characteristics to help guide clinicians when determining perioperative opioid use. Results demonstrate that interventional studies attempting to reduce opioids after TKA are needed if reductions in long-term use are to be realized in this high-risk patient population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43019-022-00148-0. BioMed Central 2022-04-05 /pmc/articles/PMC8981598/ /pubmed/35382897 http://dx.doi.org/10.1186/s43019-022-00148-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Ward, Ralph
Taber, David
Gonzales, Haley
Gebregziabher, Mulugeta
Basco, William
McCauley, Jenna
Mauldin, Patrick
Ball, Sarah
Risk factors and trajectories of opioid use following total knee replacement
title Risk factors and trajectories of opioid use following total knee replacement
title_full Risk factors and trajectories of opioid use following total knee replacement
title_fullStr Risk factors and trajectories of opioid use following total knee replacement
title_full_unstemmed Risk factors and trajectories of opioid use following total knee replacement
title_short Risk factors and trajectories of opioid use following total knee replacement
title_sort risk factors and trajectories of opioid use following total knee replacement
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981598/
https://www.ncbi.nlm.nih.gov/pubmed/35382897
http://dx.doi.org/10.1186/s43019-022-00148-0
work_keys_str_mv AT wardralph riskfactorsandtrajectoriesofopioidusefollowingtotalkneereplacement
AT taberdavid riskfactorsandtrajectoriesofopioidusefollowingtotalkneereplacement
AT gonzaleshaley riskfactorsandtrajectoriesofopioidusefollowingtotalkneereplacement
AT gebregziabhermulugeta riskfactorsandtrajectoriesofopioidusefollowingtotalkneereplacement
AT bascowilliam riskfactorsandtrajectoriesofopioidusefollowingtotalkneereplacement
AT mccauleyjenna riskfactorsandtrajectoriesofopioidusefollowingtotalkneereplacement
AT mauldinpatrick riskfactorsandtrajectoriesofopioidusefollowingtotalkneereplacement
AT ballsarah riskfactorsandtrajectoriesofopioidusefollowingtotalkneereplacement